SR ONE CAPITAL MANAGEMENT, LP Q4 2022 Filing

Filed February 8, 2023

Portfolio Value

$273.9B

Holdings

5

Report Date

Q4 2022

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
ACLXARCELLX INC.
5,500,007$170.4B62.20%
2
DSGNDESIGN THERAPEUTICS INC
6,526,476$67.0B24.44%
3
SPRYARS PHARMACEUTICALS
3,009,677$25.7B9.37%
4
NKTXNKARTA INC.
1,333,333$8.0B2.92%
5
EFTREFFECTOR THERAPEUTICS INC
6,822,114$2.9B1.07%